• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

    2/26/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email

    ALHAMBRA, Calif., Feb. 26, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, is participating in the following upcoming investor conferences:

    Astrana Health Logo (PRNewsfoto/Astrana Health, Inc.)

    • The TD Cowen 45th Annual Health Care Conference, being held in Boston, on Monday, March 3, 2025, including a fireside chat at 11:50am ET. The webcast link will be available in the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-calendar.
    • The Jefferies Value-Based Healthcare Summit, being held in Miami, on Monday, March 10, 2025, including the "Value-Based Policy: The Future of CMMI and Medicare Advantage" panel discussion at 10:00am ET, the "Technology and AI in VBC" panel discussion at 10:45am ET, and a fireside chat at 4:15pm ET.
    • The Barclays 27th Annual Global Healthcare Conference, being held in Miami, on Tuesday, March 11, 2025, including a fireside chat at 11:00am ET.
    • The Oppenheimer 35th Annual Healthcare Medtech & Services Conference, being held virtually, on Monday, March 17, 2025, including a presentation at 1:20pm ET.
    • The KeyBanc Capital Markets Healthcare Forum, being held virtually, on Tuesday, March 18, 2025, including a fireside chat at 9:45am ET.

    About Astrana Health, Inc.

    Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

    Headquartered in Alhambra, California, Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com.

    FOR MORE INFORMATION, PLEASE CONTACT:

    Investor Relations

    (626) 943-6491

    [email protected]

    Asher Dewhurst, ICR Westwicke

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-to-participate-in-upcoming-investor-conferences-302386491.html

    SOURCE Astrana Health, Inc.

    Get the next $ASTH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

    ALHAMBRA, Calif., Sept. 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that company management is participating at the Wells Fargo Healthcare Conference from Wednesday, September 3rd to Thursday, September 4th, the Morgan Stanley Global Healthcare Conference on Tuesday, September 9th with a broadcasted Fireside Chat from 5:35PM – 6:10PM ET, as well as the Baird Healthcare Conference on Wednesday, September 10th.

    9/2/25 4:30:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Reports Second Quarter 2025 Results

    Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of guidanceContinues to manage medical cost trends effectively, with trend within expectations across all lines of businessReiterates full-year 2025 guidance which is inclusive of the now-closed Prospect Health acquisitionALHAMBRA, Calif., Aug. 7, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-qual

    8/7/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call

    ALHAMBRA, Calif., July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2025, after the close of the stock market on Thursday, August 7, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

    7/22/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kitayama Mitchell W exercised 8,000 shares at a strike of $18.20 and returned $399,459 worth of shares to the company (13,214 units at $30.23), decreasing direct ownership by 25% to 15,846 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    9/15/25 4:15:35 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    COO and CFO Basho Chandan covered exercise/tax liability with 1,694 shares, decreasing direct ownership by 0.95% to 176,946 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    9/9/25 4:36:40 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 1,694 shares, decreasing direct ownership by 0.77% to 217,893 units (SEC Form 4)

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    9/9/25 4:35:04 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    SEC Filings

    View All

    Amendment: Astrana Health Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K/A - Astrana Health, Inc. (0001083446) (Filer)

    9/11/25 7:20:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form 10-Q filed by Astrana Health Inc.

    10-Q - Astrana Health, Inc. (0001083446) (Filer)

    8/7/25 5:15:59 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Astrana Health, Inc. (0001083446) (Filer)

    8/7/25 4:14:33 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Astrana Health with a new price target

    Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

    4/1/25 7:41:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    TD Cowen initiated coverage on Astrana Health with a new price target

    TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

    10/14/24 7:24:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    KeyBanc Capital Markets initiated coverage on Astrana Health

    KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

    10/11/24 7:36:28 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    View All

    Astrana Health, Inc. Reports Second Quarter 2025 Results

    Company to Host Conference Call on Thursday, August 7, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $654.8 million and adjusted EBITDA of $48.1 million, both at the higher end of guidanceContinues to manage medical cost trends effectively, with trend within expectations across all lines of businessReiterates full-year 2025 guidance which is inclusive of the now-closed Prospect Health acquisitionALHAMBRA, Calif., Aug. 7, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-qual

    8/7/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call

    ALHAMBRA, Calif., July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2025, after the close of the stock market on Thursday, August 7, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

    7/22/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Reports First Quarter 2025 Results

    Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

    5/8/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary